Skip to content
  • Home
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Latest News
  • Business
  • Finance
  • Contact Us

Search

  • Home
  • SeaPRwire
  • ACN
  • JCN
  • EQS
  • Contact
亚洲新闻、事件、深度報道

illness

ACN Newswire
Read More

FTLife launches “Protect Starter” Critical Illness Protector

indie 22 August
8 minutes

HONG KONG, Aug 22, 2022 – (ACN Newswire via SEAPRWire.com) – FTLife Insurance Company Limited (“FTLife”) is committed to helping its customers embrace the “Championing Spirit” in life. Today, it […]

SeaPRwire
Read More

Ways to protect your health coverage from life’s uncertainties

elean 29 October
6 minutes

Life can be unpredictable, and unexpected circumstances can crop up at any time, without warning. What does it take to be future-ready? Are you adequately prepared for life’s uncertainties? Having […]

ACN Newswire
Read More

New treatment option for schizophrenia Reagila(R) listed on PBS

indie 6 September
5 minutes

MELBOURNE, Sep 6, 2021 – (ACN Newswire via SEAPRWire.com) – A new treatment for schizophrenia in adults, Reagila(R) (cariprazine), was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 September, […]

SeaPRwire
Read More

New treatment option for schizophrenia – Reagila(R) – listed on PBS this week

pandora 4 September
7 minutes

– Adults living with schizophrenia will have access to a new treatment option with Reagila(R) (cariprazine) now reimbursed on the Pharmaceutical Benefits Scheme from 1 September, 2021.1 – There continues […]

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    

网站导航

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us

Search

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us
Copyright © 2020 ASEANPR.Com All rights reserved.